MBOT News and Press, Microbot Medical Inc. From 10/31/23

BRAINTREE, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY ® Robotic Surgical System, today announces additional updates regarding positive outcomes of its previously announced pivotal pre-clinical study using the LIBERTY...

The Company’s designated N otified B ody confirmed dates for conducting audits for ISO 13485 certification to ensure Microbot complies with the QMS requirements of the EU MDR The Company expects that t he full CE Mark a pproval ...

BRAINTREE, Mass., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY ® Robotic Surgical System, today announces that the United States District Court for the Southern District of New York, approved Microbot’s motion for summ...

2023-10-18 08:21:09 ET Ardelyx  ( ARDX ) +18% granted FDA nod for kidney disease therapy. Connexa Sports Technologies ( CNXA ) +14% . Spirit Aerosystems  ( SPR ) +10% Boeing Reach Agreement to Support Production Stability. Freeline Therapeutic...

A total of 48 animal targets were reached with 100% usability and technical success and no visual acute intra-operative adverse events or complications This pivotal study , together with the verification and validation stud ies , is expected to ...

BRAINTREE, Mass., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY ® Robotic Surgical System, the first single-use endovascular robotic system, announced today its partnership with a Contract Research Organization (CRO) in the U.S. Thi...

2023-09-18 13:13:33 ET For further details see: TTOO, ASTR and MBOT among mid-day movers

BRAINTREE, Mass., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) is honored to announce the continuous growing global recognition of its LIBERTY ® Robotic Surgical System, to be presented in an abstract at the Annual Congress of the Cardiovascular and Interventio...

2023-08-15 09:33:39 ET Microbot Medical ( NASDAQ: MBOT ) said on Tuesday that it had signed a manufacturing agreement with B.Y. Medimor. MBOT added that the agreement governs the manufacturing of its LIBERTY robotic surgical system. Press Release F...

BRAINTREE, Mass., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY ® Robotic Surgical System, the first single-use endovascular robotic system, announces another step in its commitment to advance the commercialization processes of LIBER...